🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Chidamide

RLC Followed by CR-CHOP in Elderly Patients with Newly-diagnosed DEL NCT06674096Phase 21 site📍 Hangzhou Zhejiang Cancer Hospital · Tests: RLC-CRCHOP Chidamide, Venetoclax, and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia NCT06386302NA1 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: Chidamide, Venetoclax, azacitidine A Prospective, Single-Arm, Single-Center Phase II Study Evaluating the Efficacy and Safety of Chidamide Combined With PD-L1 Inhibitor, Carboplatin, and Etoposide as First-Line Treatment in Patients With Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) NCT07373964Phase 21 site📍 Shenyang China Medical University, China · Tests: Chidamide Tablets； PD-L1 Inhibitor (as per chosen drug's prescribing information)；Carboplatin； Etoposide Single Arm Study of Post-transplant Azacitidine and Chidamide for Prevention of Acute Myelogenous Leukemia Relapse NCT05270200Phase 1, Phase 21 site📍 Guanzhou Zhujiang Hospital · Tests: Azacitidine, Chidamide Sintilimab Combined With Chidamide in Treating Peripheral T Cell Lymphoma NCT04512534Phase 21 site📍 Shanghai Fudan University · Tests: PD-1 antibody+ HDAC inhibitor Chidamide Combined With Brentuximab Vedotin Regimen for CD30+ PTCL Patients NCT07074457NA1 site📍 Suzhou The First Affiliated Hospital of Soochow University · Tests: Induction therapy-3 cycles of BvC (Brentuximab vedotin plus Chidamide), Consolidation therapy- 3 or 6 cycles of BvC(Bre… Venetoclax, Chidamide, and Chiglitazar Sodium (VCC) in Patients With Relapsed/Refractory Acute Myeloid Leukemia NCT07783100Phase 21 site📍 Xiamen The First Affiliated Hospital of Xiamen University · Tests: venetoclax, chidamide, and chiglitazar sodium (VCC) An Open-label, Single-arm, Multicenter Phase II Clinical Study of Azacitidine, Chidamide Combined With PD-1 Monoclonal Antibody in the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma. NCT07598578EARLY Phase 11 site📍 Suzhou Second Affiliated Hospital of Soochow University · Tests: Azacitidine (AZA) A Study of Tucidinostat in Combination With Sintilimab and Bevacizumab in MSS/pMMR Colorectal Cancer Patients NCT06497985Phase 31 site📍 Guangzhou Chipscreen Biosciences, Ltd. · Tests: Tucidinostat, Sintilimab, Bevacizumab, Fruquintinib A Randomized Clinical Trial Comparing Chi-BEAM With BEAM Regimen Combined With ASCT for the Treatment of ND PTCL NCT05931263Phase 31 site📍 Nanjing The First Affiliated Hospital with Nanjing Medical Universi… · Tests: C-BEAM Regimen, BEAM Regimen A Study of Chidamide With AZA in MRD Positive AML After Transplant NCT06066905NA1 site📍 Guangzhou Guangdong Provincial People's Hospital · Tests: chidamide and azacitidine Venetoclax Combining Chidamide and Azacitidine (VCA) in the Treatment of R/R AML NCT05305859Phase 21 site📍 Xiamen The First Affiliated Hospital of Xiamen University · Tests: venetoclax combining chidamide and azacitidine (VCA) SHR2554 Clinical Study of Chidamide in the Treatment of T-cell Lymphoma NCT06122389Phase 31 site📍 Beijing Jiangsu HengRui Medicine Co., Ltd. · Tests: SHR2554; Chidamide analog tablets, SHR2554 analog tablets; Chidamide Randomized Study of ABC-14 Regimen Compared With "3+7" Standard Induction Therapy or AB-14 for ND AML NCT06451861Phase 213 sites📍 Dongguan📍 Foshan📍 Guangzhou Guangdong Provincial People's Hospital · Tests: Chidamide, Venetoclax, azacitidine, Anthracyclines or anthraquinones, cytarabine A Clinical Study on the Efficacy and Safety of Fruquintinib in Combination With PD-1 Monoclonal Antibody and Chidamide in Refractory MSS Metastatic Colorectal Cancer NCT06979908Phase 21 site📍 Changchun The First Hospital of Jilin University · Tests: Fruquintinib+Sintilimab+Chidamide Chidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular Subtypes NCT06891157Phase 21 site📍 Nanjing The First Affiliated Hospital with Nanjing Medical Universi… · Tests: Chidamide plus R-CHOP Chidamide, Lenalidomide, and Rituximab in Newly Diagnosed Elderly/unFit DE-DLBCL NCT07884708Phase 21 site📍 Nanjing The First Affiliated Hospital with Nanjing Medical Universi… · Tests: Chidamide in combination with Lenalidomide and Rituximab (CR2) Enhancing CAR-T Cell Therapy Efficacy in B-cell Lymphoma Via Chidamide and PD-1 Inhibitor Combination. NCT07489989Phase 21 site📍 Beijing Daihong Liu · Tests: CAR-T Cell Therapy + Chidamide and PD-1 Inhibitor Maintenance Chidamide Maintenance for MRD-Positive Double-Expressor DLBCL in First Complete Remission NCT07507318Phase 21 site📍 Shanghai Rong Tao · Tests: Chidamide Chidamide in Combination With Azacitidine, Liposomal Mitoxantrone, and Prednisone (CAMP Regimen) for the Treatment of Previously Untreated Nodal TFH Cell Lymphoma NCT05958719Phase 21 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: Chidamide, Azacitidine, liposomal mitoxantrone, prednisone Prospective, Single Arm, Single Center Study of Duvelisib Combined With Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma (PTCL) NCT05976997Phase 21 site📍 Wuhan Liling Zhang · Tests: Duvelisib, Chidamide Comparison of VA (Venetoclax, Azacitidine), VACl (VA, Cladribine), VACh (VA, Chidamide), and Alternating VACl/VACh in Newly Diagnosed Acute Myeloid Leukemia NCT06532552Phase 21 site📍 Suzhou The First Affiliated Hospital of Soochow University · Tests: VACl, VACh, VACl Alternating With VACh, VA Glofitamab Combination With Chidamide in Patients With Recurrent/Refractory DLBCL NCT06570447Phase 21 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: Glofitamab, Chidamide Chidamide Prevents Recurrence of High-risk AML After Allo-HSCT NCT05682755Phase 1, Phase 21 site📍 Chengdu Sichuan University · Tests: Chidamide Golidocitinib Combined With Mitoxantrone Hydrochloride Liposome or Chidamide in the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma NCT07093710Phase 1, Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Golidocitinib, Mitoxantrone Hydrochloride Liposome, Chidamide A Retrospective Clinical Study on the First-line Maintenance Treatment of PTCL With Chidamide. NCT05967949n/a1 site📍 Nanjing The First Affiliated Hospital with Nanjing Medical Universi… · Tests: chidamide CHiR Therapy for Elderly DLBCL Intolerant to Chemo NCT06764017Phase 21 site📍 Ningbo First Affiliated Hospital of Ningbo University · Tests: CHiR-DEL Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic Cholangiocarcinoma NCT07570849Phase 21 site📍 Shanghai Shanghai Zhongshan Hospital · Tests: Chidamide, Gemcitabine, cisplatin, immune checkpoint inhibitor Treatment of Chidamide and Venetoclax for Retinoic Acid and Arsenic Resistant Acute Promyelocytic Leukemia NCT05881265Phase 25 sites📍 Huai'an📍 Nanchang📍 Shanghai Shanghai Jiao Tong University School of Medicine · Tests: Chidamide+venetoclax Chidamide for Maintenance Treatment of HBV-infected Diffuse DLBCL in Patients Initially Treated With R-CHOP NCT07493109Phase 31 site📍 Changchun Ou Bai, MD/PHD · Tests: Chidamide, Entecavir Tablets
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy